ZIDA Sock for Overactive Bladder

This trial tests a new method to assist people with overactive bladder (OAB) who continue to experience symptoms despite medication. It examines the ZIDA Control Sock, a wearable device that sends gentle electrical signals near the ankle to determine if it helps reduce bladder issues when used alongside usual treatments. The trial targets adults with OAB-wet, characterized by sudden urges to urinate that lead to leaks, who have been on stable medication for at least four weeks. Participants will use the sock once a week at home for 12 weeks while continuing their regular medication. As an unphased trial, this study provides a unique opportunity to explore innovative treatment options for OAB.

No, you will not have to stop taking your current medications. The trial requires participants to continue their prescribed therapy while using the ZIDA Control Sock.

Research has shown that the ZIDA Control Sock is safe for individuals with overactive bladder (OAB). Many studies and sources support this finding. The FDA has approved the ZIDA device, confirming it meets safety standards for treating incontinence and OAB. Studies describe the device as safe and effective in reducing symptoms such as urgent and frequent urination, both day and night. Additionally, the device is noninvasive, requiring no surgery or internal procedures, which often makes treatments easier to manage. No major negative effects have been reported so far, suggesting that users tolerate the ZIDA Sock well.¹²³⁴⁵

The ZIDA Control Sock is unique because it offers a non-drug approach to managing overactive bladder by incorporating wearable technology. Unlike standard treatments, which include medications like anticholinergics or beta-3 adrenergic agonists, this sock is used as an add-on therapy, potentially enhancing the effects of existing medications. Researchers are excited about this treatment because it provides a novel, convenient delivery method that may improve patient compliance and comfort. Additionally, the sock is designed for home use, which could make it an accessible option for many individuals looking to manage their symptoms more effectively.

Studies have shown that the ZIDA Control Sock can effectively help people with overactive bladder (OAB). Research indicates that using the ZIDA sock can significantly reduce sudden urges to urinate, with some studies reporting at least a 50% decrease in these urgent episodes and a 30% reduction in accidents over a 24-hour period. The sock delivers gentle electrical pulses near the ankle, calming the nerves that can cause bladder control problems. Feedback from previous trials also shows improvements in quality of life when using the sock. In this trial, participants will continue their usual pharmacologic treatment for OAB and use the ZIDA Control Sock as an add-on therapy. Overall, the ZIDA Control Sock has proven to be a promising additional treatment for those still experiencing OAB symptoms despite medication.¹⁶⁷⁸⁹